Near final height in patients with idiopathic growth hormone deficiency: A single-centre experience

Erdal Kurnaz1, Semra Çetinkaya1, Zehra Aycan1

  • 1Clinic of Pediatric Endocrinology, Dr. Sami Ulus Obstetrics and Gynecology and Pediatrics Training and Research Hospital, Ankara, Turkey.

Insights

Children with growth hormone deficiency (GHD) treated with recombinant human growth hormone (rhGH) can achieve near final height (NFH) within the mid-parental height range. Starting rhGH therapy during puberty may lead to greater height gains.

Area of Science:

  • Pediatric Endocrinology
  • Growth Hormone Therapy
  • Genetics

Background:

  • Growth hormone deficiency (GHD) impacts children's final height.
  • Recombinant human growth hormone (rhGH) is a standard treatment for GHD.
  • Understanding factors influencing near final height (NFH) is crucial for optimizing treatment outcomes.

Purpose of the Study:

  • To analyze near final height (NFH) data in children with GHD treated with rhGH.
  • To compare NFH outcomes between isolated GHD (IGHD) and multiple pituitary hormone deficiency (MPHD) groups.
  • To evaluate the impact of pubertal status on rhGH treatment efficacy.

Main Methods:

  • Retrospective analysis of NFH data in children with GHD receiving rhGH therapy.
  • Patients were categorized into IGHD and MPHD groups.
  • Data were further stratified by gender, pre-pubertal/pubertal status, and puberty type.

Main Results:

  • rhGH therapy initiated at a median age of 12.1 years for IGHD and 9.1 years for MPHD.
  • Height Standard Deviation Scores (SDSs) at therapy onset were significantly lower in the MPHD group.
  • NFH SDSs were comparable between groups (-1.8 for IGHD, -1.6 for MPHD), but delta height SDSs were significantly higher in the MPHD group (2.6 vs 1.4).
  • Total height gain was similar for pre-pubertal (1.4 SDS) and pubertal (1.3 SDS) starters.

Conclusions:

  • Approximately 85% of patients achieved their genetic height potential.
  • Greater height gains (delta height SDSs) were observed in patients initiating rhGH treatment during puberty.
  • Achieving NFH within the mid-parental height range is feasible for patients starting rhGH therapy during puberty.
Abstract

Related Concept Videos

Types of Hormones02:13

Types of Hormones

Hormones can be classified into three main types based on their chemical structures: steroids, peptides, and amines. Their actions are mediated by the specific receptors they bind to on target cells.
83.9K
Types of Hormones01:21

Types of Hormones

Hormones are classified into four main groups: steroids, eicosanoids, amino acid-based derivatives, and peptide hormones.
Steroids and eicosanoids fall under the category of lipid-soluble hormones. Steroids are derived from cholesterol and feature four interconnected carbon rings with variable side chains. Notable examples include estradiol from ovaries and testosterone from testes, exemplifying the critical roles of these lipid-soluble hormones in reproductive physiology. Eicosanoids, derived...
7.2K
Plant Hormones01:56

Plant Hormones

Plant hormones—or phytohormones—are chemical molecules that modulate one or more physiological processes of a plant. In animals, hormones are often produced in specific glands and circulated via the circulatory system. However, plants lack hormone-producing glands.
27.7K